enprofylline

This page covers all enprofylline drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Adenosine receptor A3, Adenosine receptor A1, Adenosine receptor A2a.

Targets

Adenosine receptor A3, Adenosine receptor A1, Adenosine receptor A2a

Phase 2 pipeline (1)

• 3-Propylxanthine · Hematology
  Enprofylline works by blocking the adenosine receptor A2b, which helps to increase blood flow and reduce inflammation.

Patent intelligence

• enprofylline patent landscape — aggregated cliff calendar, attackable patents, originator estates